Apellis Pharmaceuticals, Inc. (APLS)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.253B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 150.8% |
| Valuation | |
| PE Ratio | 41.01 |
| PE Ratio (Forward) | |
| PS Ratio | 4.772 |
| Price to Book Value | 12.66 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.147 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 82.47% |
Profile
| N/A |
| URL | http://www.apellis.com |
| Investor Relations URL | https://investors.apellis.com/ |
| HQ State/Province | Massachusetts |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 30, 2026 (est.) |
| Last Earnings Release | May. 07, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| N/A |
| URL | http://www.apellis.com |
| Investor Relations URL | https://investors.apellis.com/ |
| HQ State/Province | Massachusetts |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 30, 2026 (est.) |
| Last Earnings Release | May. 07, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |